2019
|
Invention
|
Modified oligonucleotides and methods of use. Methods and compositions for reducing drug resistan... |
2018
|
Invention
|
Oligonucleotide constructs and uses thereof. Oligodeoxynucleotide-based immunostimulatory Toll-Li... |
|
Invention
|
Substituted nucleosides, nucleotides and analogs thereof. Picornaviridae, Flaviviridae, Filovirid... |
|
Invention
|
Galnac derivatives. Modified oligonucleotides comprising a GalNAc moiety of the present disclosur... |
|
Invention
|
Modified nucleoside phosphoramidites. The present disclosure relates to compounds and composition... |
|
Invention
|
Methods for treating pneumoviruses. Described herein are methods for treating and/or ameliorating... |
|
Invention
|
Methods of preparing substituted nucleoside analogs. Disclosed herein are methods of preparing a ... |
|
Invention
|
Substituted nucleosides, nucleotides and analogs thereof.
Disclosed herein are nucleosides, nucl... |
2017
|
Invention
|
Oligonucleotide targeting strategy for hbv cccdna. The present disclosure provides oligonucleotid... |
|
Invention
|
Methods for treating respiratory syncytial virus infection. The present invention relates to dosi... |
|
Invention
|
Methods for treating respiratory syncytial virus infection.
The present invention relates to dos... |
|
Invention
|
Modified oligonucleotides and methods of use. Modified oligonucleotides comprising modifications ... |
|
Invention
|
Antiviral compounds.
Disclosed herein are new antiviral compounds, together with pharmaceutical ... |
|
Invention
|
(s)-8-(benzhydryl )-6-isopropyl-3,5-dioxo- 5, 6,7,8,-tetrahydro-3h-pyrazino-[1,2-b]pyridazin-yl-i... |
|
Invention
|
Method of preparing aza-pyridone compounds. Disclosed herein are methods for obtaining aza-pyrido... |
|
Invention
|
Acyclic antivirals. Disclosed herein are nucleotide analogs, methods of synthesizing nucleotide a... |
|
Invention
|
Fxr modulators and methods of their use. The present disclosure is directed to modulators of farn... |
2016
|
Invention
|
Substituted nucleosides, nucleotides and analogs thereof. Disclosed herein are nucleosides, nucle... |
|
Invention
|
Solid forms of a thiophosphoramidate nucleotide prodrug. The present application relates to solid... |
|
Invention
|
Cyclic nucleotide analogs.
Disclosed herein are cyclic nucleotide analogs, methods of synthesizi... |
|
Invention
|
Azido nucleosides and nucleotide analogs.
Disclosed herein are nucleosides, nucleotides and anal... |
|
Invention
|
Aza-pyridone compounds and uses thereof. Disclosed herein are aza-pyridone compounds, pharmaceuti... |
|
Invention
|
Compositions and methods for the treatment of norovirus infection.
Compositions and methods for ... |
|
Invention
|
Antiviral compounds. Disclosed herein are new antiviral compounds, together with pharmaceutical c... |
2015
|
Invention
|
Substituted nucleosides, nucleotides and analogs thereof. Disclosed herein are nucleotide analogs... |
|
Invention
|
Substituted nucleosides, nucleotides and analogs thereof.
Disclosed herein are nucleotide analog... |
|
Invention
|
Combination therapy for treating a paramyxovirus.
Disclosed herein are a combination of compound... |
|
Invention
|
Combination therapy for treating a paramyxovirus. Disclosed herein are a combination of compounds... |
|
Invention
|
Methods for treating paramyxoviruses. Described herein are methods for treating and/or ameliorati... |
|
Invention
|
Methods for treating paramyxoviruses.
Described herein are methods for treating and/or ameliorat... |
|
Invention
|
Methods of preparing substituted nucleotide analogs. Disclosed herein are methods of preparing a ... |
|
Invention
|
Use of nucleosides and nucleotides to treat filoviridae viral infection. Disclosed herein are nuc... |